Role of IL-10 in Urinary Bladder Carcinoma and Bacillus Calmette-Guerin Immunotherapy

American Journal of Immunology - United States
doi 10.3844/ajisp.2012.1.9
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Science Publications

Related search

Bacillus Calmette–Guerin Immunotherapy for Urothelial Carcinoma of the Bladder

Immunotherapy
OncologyAllergyImmunology
2009English

Intravesical Bacillus Calmette-Guerin Instillation Therapy for Superficial Bladder Cancers

Japanese Journal of Urology
Urology
1990English

Efficacy and Effectiveness of Vaccination With Bacillus Calmette-Guerin

Juntendo Medical Journal
2001English

Disseminated Granulomatous Disease From Intravesical Instillation of Bacillus Calmette-Guerin

Case Reports in Oncological Medicine
Oncology
2018English

Systemic Bacillus Calmette-Guerin (BCG) Activates Natural Suppressor Cells.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1978English

Blockade of IL-10 Signaling During Bacillus Calmette-Guerin Vaccination Enhances and Sustains Th1, Th17, and Innate Lymphoid IFN- And IL-17 Responses and Increases Protection to Mycobacterium Tuberculosis Infection

Journal of Immunology
AllergyImmunology
2012English

Re: Side Effects of Bacillus Calmette-Guerin (BCG) in the Treatment of Intermediate- And High-Risk Ta, T1 Papillary Carcinoma ...

Journal of Urological Surgery
2015English

Comparison of Intravesical Bacillus Calmette‑Guerin and Mitomycin C Administration for Non‑muscle Invasive Bladder Cancer: A Meta‑analysis and Systematic Review

Oncology Letters
Cancer ResearchOncology
2016English

Tuberculous Psoas Abscess and Worsening Vascular Aneurysm; All From Bacillus Calmette-Guerin (BCG) Therapy?

American Journal of Case Reports
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy